Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 double-masked multinational study of darapladib in center-involved diabetic macular edema
2011-002944-28Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of darapladib in diabetic macular edema (DME), sponsored by GSK. Primary endpoints: Mean change from baseline in ETDRS best-corrected visual acuity and Mean change from baseline in SD-OCT central subfield retinal thickness. Started Nov 2011; status: completed.
02
Drugs
darapladib
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on 2011-002944-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002944-28.